联合治疗|“修复”人体葡萄糖传感器：播种糖尿病治疗的新希望！( 四 )

资料来源：
1.Irwin DM, Tan H. Molecular evolution of the vertebrate hexokinase gene family: Identification of a conserved fifth vertebrate hexokinase gene[J]. Comp Biochem Physiol Part D Genomics Proteomics, 2008, 3(1):96-107.
2.MatschinskyFM, WilsonDF. The central role of glucokinase in glucose homeostasis: a perspective 50 years after demonstrating the presence of the enzyme in islets of Langerhans[J]. Front Physiol, 2019, 10:148-163.
3.Li C, Liu C, Nissim I, et al. Regulation of glucagon secretion in normal and diabetic human islets by γ-hydroxybutyrate and glycine[J]. J Biol Chem, 2013, 288(6):3938-51.
4.Haeusler RA, Camastra S, Astiarraga B, et al. Decreased expression of hepatic glucokinase in type 2 diabetes[J]. Mol Metab. 2014, 4(3):222-6.
5.Caro JF, Triester S, Patel VK, et al. Liver glucokinase: decreased activity in patients with type II diabetes[J]. Horm Metab Res, 1995, 27(1):19-22.
6.Clore JN, Stillman J, Sugerman H. Glucose-6-phosphatase flux in vitro is increased in type 2 diabetes[J]. Diabetes. 2000, 49(6):969-74.
7.Grewal AS, Sekhon BS, Lather V. Recent updates on glucokinase activators for the treatment of type 2 diabetes mellitus[J]. Mini Rev Med Chem. 2014, 14(7):585-602.
8.Li Chen, Y Zhang,et al. ADA 75th Scientific Session, June 5-9, 2015, Boston.
9.Wang P, Liu H, Chen L, et al. Effects of a Novel Glucokinase Activator, HMS5552, on Glucose Metabolism in a Rat Model of Type 2 Diabetes Mellitus[J]. J Diabetes Res, 2017, 2017:5812607.
10.Bergstrom RW, Wahl PW, Leonetti DL, Fujimoto WY. Association of fasting glucose levels with a delayed secretion of insulin after oral glucose in subjects with glucose intolerance[j]. J Clin Endocrinol Metab, 1990, 71(6):1447-53.
11.DL Zhu, et al. ADA 75th Scientific Session, 2015, Boston.
12.Zhu D, Gan S, Liu Y, et al. Dorzagliatin monotherapy in Chinese patients with type 2 diabetes: a dose-ranging, randomised, double-blind, placebo-controlled, phase 2 study[J]. Lancet Diabetes Endocrinol, 2018, 6(8):627-636.
13.Hua Medicine for 2020 ADA Scientific Sessions.
14.RISE Consortium. Lack of Durable Improvements in β-Cell Function Following Withdrawal of Pharmacological Interventions in Adults With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes[J]. Diabetes Care, 2019, 42(9):1742-1751.
来源：医学界
校对：臧恒佳
责编：潘颖